恆指跌逾360點考驗21,700 騰訊、潤地、恆隆地產、京東及舜宇挫3%至6%
中國官方1月製造業PMI升至50.1符預期,非製造業PMI升至54.4遠勝預期。然而,亞太股市今天全面反覆受壓,恆指失守10天線,午後跌幅擴至362點或1.6%,報21,707,總成交額1,092億元。此外,科指及國指反覆續跌2%及1.6%,各報4,489及7,372。
藍籌股普遍反覆向下,尤其是舜宇(02382.HK)跌破10天線,最低見103元,現報103.4元,續挫5.6%。阿里(09988.HK)、百度(09888.HK)、騰訊(00700.HK)及京東(09618.HK)續跌2.8%-3.1%,騰訊及京東分別報375.2元及230元。
地產股新地(00016.HK)、恆地(00012.HK)、新世界(00017.HK)、中海外(00688.HK)、龍湖(00960.HK)、潤地(01109.HK)及恆隆地產(00101.HK)挫2.5%-5.9%、潤地及恆隆地產分別報37.7元及14.66元,挫4.1%-5.9%。
醫藥相關股以藥明生物(02269.HK)、石藥(01093.HK)及中生製藥(01177.HK)沽壓較大,股價跌逾3%-4%。
金融股以招行(03968.HK)及港交所(00388.HK)沽壓較大,股價跌2.2%-2.9%。
然而,料全年多賺逾4倍的比亞迪(01211.HK)曾逆升4.8%高見251元創五個月高,現報245.8元,回升2.6%。小米(01810.HK)、聯想集團(00992.HK)及金沙中國(01928.HK)回升逾1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.